ProfileGDS4718 / 224667_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 94% 92% 94% 94% 91% 92% 92% 93% 93% 90% 93% 90% 91% 91% 92% 91% 92% 91% 97% 92% 92% 91% 92% 94% 89% 93% 96% 93% 93% 91% 92% 94% 91% 91% 89% 94% 92% 93% 90% 92% 94% 93% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8754893
GSM549102patient 115, normal, homogenized [OPG study]9.8963694
GSM549104patient 119, normal, homogenized [OPG study]9.6751792
GSM549108patient 138, normal, homogenized [OPG study]9.8614794
GSM549119patient 077, normal, homogenized [OPG study]9.9996494
GSM549133patient 032, cancer, homogenized [OPG study]9.474591
GSM549139patient 042, cancer, homogenized [OPG study]9.5030192
GSM549099patient 107, normal, homogenized [OPG study]9.6104392
GSM549109patient 139, normal, homogenized [OPG study]9.7962393
GSM549110patient 046, normal, homogenized [OPG study]9.7679293
GSM549114patient 063, normal, homogenized [OPG study]9.4171790
GSM549122patient 082, normal, homogenized [OPG study]9.8068993
GSM549134patient 033, cancer, homogenized [OPG study]9.2720190
GSM549136patient 036, cancer, homogenized [OPG study]9.3798391
GSM549140patient 044, cancer, homogenized [OPG study]9.389991
GSM549111patient 047, normal, homogenized [OPG study]9.7246992
GSM549113patient 057, normal, homogenized [OPG study]9.4928691
GSM549132patient 031, cancer, homogenized [OPG study]9.5686692
GSM549137patient 038, cancer, homogenized [OPG study]9.2487591
GSM549142patient 047, cancer, homogenized [OPG study]10.610997
GSM549100patient 110, normal, homogenized [OPG study]9.5963592
GSM549107patient 135, normal, homogenized [OPG study]9.6260892
GSM549115patient 068, normal, homogenized [OPG study]9.635591
GSM549116patient 072, normal, homogenized [OPG study]9.6173292
GSM549120patient 078, normal, homogenized [OPG study]9.9916394
GSM549131patient 030, cancer, homogenized [OPG study]9.1054289
GSM549118patient 074, normal, homogenized [OPG study]9.8655793
GSM549129patient 027, cancer, homogenized [OPG study]10.391796
GSM549123patient 088, normal, homogenized [OPG study]9.853293
GSM549124patient 006, cancer, homogenized [OPG study]9.6326493
GSM549126patient 015, cancer, homogenized [OPG study]9.2397891
GSM549128patient 025, cancer, homogenized [OPG study]9.5441292
GSM549103patient 117, normal, homogenized [OPG study]9.9170194
GSM549117patient 073, normal, homogenized [OPG study]9.4893691
GSM549138patient 041, cancer, homogenized [OPG study]9.3121691
GSM549141patient 045, cancer, homogenized [OPG study]9.120989
GSM549130patient 028, cancer, homogenized [OPG study]9.7204294
GSM549101patient 111, normal, homogenized [OPG study]9.5168492
GSM549105patient 128, normal, homogenized [OPG study]9.6669493
GSM549106patient 134, normal, homogenized [OPG study]9.363790
GSM549112patient 048, normal, homogenized [OPG study]9.5749192
GSM549125patient 011, cancer, homogenized [OPG study]9.8722994
GSM549127patient 024, cancer, homogenized [OPG study]9.5554693
GSM549135patient 035, cancer, homogenized [OPG study]9.3759391